MAY 27, 2026 · REGULATORY APPROVAL
FDA approval: Carboprost Tromethamine
U.S. Food and Drug Administration
FDA approval of a generic carboprost tromethamine injectable formulation; represents regulatory authorization but does not report clinical trial data or comparative efficacy.
Reported
Approval date2026-05-27
Formulation strength0.25 mg base/mL